ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Retransplantation"

  • 2018 American Transplant Congress

    Can Immunosuppression Maintenance after Renal Allograft Failure Prevent Further Sensitization?

    A. Mena-Gutierrez, K. Alquadan, A. Santos, K. Womer, M. Casey.

    University of Florida, Gainesville.

    After renal graft failure, retransplantation(ReTx) becomes more difficult due to sensitization to alloantigens. In 2013, our center opened a specialty clinic to maintain immunosuppression(IS) after…
  • 2018 American Transplant Congress

    Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

    K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.

    Medicine-Nephrology, UCLA, Los Angeles, CA.

    Background: With the prioritization of age ≤ 18 years old at the time of registration on the kidney transplant waiting list in the United States,…
  • 2017 American Transplant Congress

    Liver Retransplantation: The Largest Post MELD Single Center Experience.

    F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.

    Surgery, University of California Los Angeles, Los Angeles, CA

    OBJECTIVE: Analyze post MELD liver retransplantation (Re-OLT) and identify recipient and donor preoperative risk factors associated with poor patient outcomes.BACKGROUND: Re-OLT is a high risk…
  • 2017 American Transplant Congress

    Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.

    J. Ramirez,1 H. Aghil,1 M. Baz,3 B. Sawaya,1 N. Rajagopalan,2 X. Mei,3 R. Gedaly,3 A. El-Husseini.1

    1Division of Nephrology, University of Kentucky, Lexington, KY; 2Division of Cardiology, University of Kentucky, Lexington, KY; 3Division of Transplant Surgery, University of Kentucky, Lexington, KY

    Introduction: The aim of the study is to evaluate patient and kidney allograft survivals in primary, repeat, and kidney after nonrenal organ transplantation using national…
  • 2017 American Transplant Congress

    De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.

    K. Atiemo,1 B. Ho,1 H. Bhagat,2 E. Lee,2,3 A. Daud,1 R. Kang,1 S. Montag,1,4 L. Zhao,1,4 J. Schwartz,2 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Astellas Pharma Global Development, Northbrook; 3Now with UCB, Atlanta; 4Dept of Preventive Medicine, Northwestern University, Chicago

    Retransplant (RTx) patients are often sensitized due to donor-specific antibody (DSA) formation, with higher acute rejection rates during subsequent transplants vs patients without DSA. However,…
  • 2017 American Transplant Congress

    Continuation of Immunosuppression Appears to Protect Against Allosensitization in Patients Listed for a Second Kidney Transplant.

    S. Kuppachi,1 M. Sanders,1 R. Kalil,1 Z. Stewart,2 C. Thomas.1

    1Internal Medicine, University of Iowa, Iowa City, IA; 2Transplant Surgery, University of Iowa, Iowa City, IA

    Purpose: The current standard of practice after allograft loss is to discontinue immunosuppression (IS) to decrease complications related to prolonged exposure. There is a paucity…
  • 2017 American Transplant Congress

    Impact of Inflammatory Bowel Disease on Survival and Risk of Retransplantation of Primary Sclerosing Cholangitis Patients Following Liver Transplantation: UNOS Data Analysis.

    O. Mousa,1 N. Patel,1 J. Corral,1 D. Lee,2 J. Nguyen,2 K. Croome,2 D. Harnois.2

    1Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL; 2Transplant, Mayo Clinic, Jacksonville, FL

    Background: The impact of inflammatory bowel disease (IBD) on outcomes after liver transplantation (LT) for primary sclerosing cholangitis (PSC) has been inconclusive. Previous reports suggested…
  • 2017 American Transplant Congress

    Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.

    M. Barry,1 M. Gupta,2 D. Goldberg,3 M. Levine,2 D. Simpson,2 K. Olthoff,2 A. Shaked,2 P. Abt.2

    1School of Medicine, University of Pennsylvania, Philadelphia, PA; 2Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; 3Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA

    Introduction: Retransplantation with a third liver allograft is controversial with significant technical and medical challenges. National outcomes have not been described. We hypothesize that prior…
  • 2017 American Transplant Congress

    HLA Alloimmunization According to the Different Immunization Events and Consequences on Access to Kidney Transplantation.

    V. Pernin,1 A. Cros,1 I. Szwarc,1 C. Rene,2 J.-F. Eliaou,2 V. Garrigue,1 G. Mourad,1 M. Le Quintrec-Donnette.1

    1Department Nephrology and Transplantation, CHU Lapeyronie, Montpellier, France; 2Department of Immunology, CHU St ELoi, Montpellier, France

    Patients awaiting solid organ transplantation may develop anti-HLA antibodies after sensitization events such as transfusions, pregnancies or previous transplantations. The aim of our work was…
  • 2017 American Transplant Congress

    Status 1 Liver Transplantation: Changes in Characteristics and Outcome Over Time.

    H. Truong, L. Lacar, L. Wong.

    General Surgery, University of Hawaii, JABSOM, Honolulu, HI

    Purpose: Approximately 5% of liver transplants (LT) annually require this urgently as “Status 1." The aim of this study is to characterize patients who received…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences